Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

NCT06221800 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2026-02-05

No results posted yet for this study

Summary

This is a pilot study collecting data on the diversity and composition of gut microbiomes in subjects with advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) while receiving treatment for NSCLC.

Conditions

  • Non Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST

Microbiome

Stool and saliva samples will be collected

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Misako Nagasaka, MD,PhD · Chao Family Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06221800 on ClinicalTrials.gov